Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 3 of 19
- Allies Group Inc. recalls THE ONE SPF 50 INVISIBLE SUNSCREEN GELFDASubpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
- Mylan Pharmaceuticals Inc recalls Prasugrel TabletsFDAFailed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
- Sage Products, LLC recalls % Chlorhexidine Gluconate* ClothFDACross Contamination with Other Products
- OPTIMAL BALANCE PHARMACY recalls Glutathione 200 mg/mLFDAMicrobial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
- American Health Packaging recalls Buprenorphine Sublingual Tablets (C-III)FDALabeling: Label Mix-up
- Baxter Healthcare Corporation recalls .9% Sodium Chloride Injection USP 500 mLFDAPresence of particulate matter: Particulates identified as fiberglass
- Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) InjectionFDAFailed Stability Specifications: Out of specification stability result for the protein concentration profile.
- Golden State Medical Supply Inc. recalls Prasugrel HCIFDAFailed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
- Teva Pharmaceuticals USA, Inc recalls traZODone Hydrochloride TabletsFDAPresence of Foreign Tablets/Capsules
- Mylan Pharmaceuticals Inc recalls Carton labelFDAFailed Dissolution Specifications
- Lexia LLC recalls Broadway Joe's Pain CreamFDACGMP Deviations: Potential contamination of raw material
- Supernus Pharmaceuticals, Inc. recalls Trokendi XRFDAFailed dissolution specifications.
- Lupin Pharmaceuticals Inc. recalls Clobetasol Propionate Cream USPFDAFailed content uniformity specifications.
- Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection)FDAPresence of particulate matter: glass and stopper piece
- ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium TabletsFDASubpotent Drug
- Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) InjectionFDAPresence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
- Church & Dwight Co., Inc. recalls ZicamFDACGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
- B BRAUN MEDICAL INC recalls Lactated Ringer's Injection USPFDAPresence of Particulate matter.
- Apotex Corp. recalls Paxil CRFDAFailed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
- Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USPFDAFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
- JAMP Temozolomide: Out-of-Specification (Assay)Health CanadaProduct quality
- Apo-Semaglutide Injection : Incorrect dose displayHealth CanadaProduct quality
- Semaglutide Injection : Out-of-Specification (Impurity)Health CanadaProduct quality
- Mylan Pharmaceuticals Inc recalls Acamprosate CalciumFDAFailed Dissolution Specifications
- American Regent, Inc. recalls Cyanocobalamin injection USP and 9 moreFDAPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
- Regeneron Pharmaceuticals Inc recalls Libtayo (cemiplimab-rwlc) InjectionFDALack of Assurance of Sterility
- Shilpa Medicare Limited recalls PEMRYDI RTU (pemetrexed injection) and 1 moreFDADiscolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
- Fresenius Kabi USA, LLC recalls Morphine Sulfate InjectionFDALabeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Carbamazepine TabletsFDACGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
- Golden State Medical Supply Inc. recalls Carbamazepine TabletsFDACGMP deviations: tablets with black specks.
- Twins Herbal Products: Undeclared prescription drug (sildenafil)Health CanadaUndeclared substance
- Importation of South Korean-Authorized BONKY Injection, 1 mcg/mL Calcitriol, due to the Current Shortage of Canadian-Authorized Calcitriol Injection USP, 1 mcg/mLHealth CanadaSupply - Product safety - Labelling
- CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.Health CanadaProduct quality
- Buy-Herbal recalls Kian Pee Wan CapsulesFDAMarketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
- Baxter Healthcare Corporation recalls Cefazolin in DextroseFDAPresence of Particulate Matter
- Apollo Care, LLC recalls SEMAGLUTIDE 7.5mg (5mg/mL) and 10 moreFDAPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Victory Medical Center Pharmacy recalls Glutathione (MDV)FDAMicrobial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
- Liebel-Flarsheim Company LLC recalls Optiray Imaging Bulk Package-350FDAPresence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
- Heritage Pharmaceuticals Inc recalls CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTIONFDAPresence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
- Prestige Brands Holdings recalls CLEAR EYES Maximum Itchy Eye ReliefFDALack of assurance of sterility. The recall is due to potential contamination
- Shoolin Pharma Chem LLP recalls SILDENAFIL CITRATE USP and 1 moreFDACGMP Deviations:Noted during FDA inspection
- Novartis Pharmaceuticals Corporation recalls Diovan (valsartan) 160 mgFDAFailed Dissolution Specifications
- Lactated Ringer's Injection USP: Presence of Particulate MatterHealth CanadaProduct quality
- Adequan I.M: Presence of particulate matterHealth CanadaProduct quality
- pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.Health CanadaContamination
- Sunny Pharmtech Inc. recalls Cyclophosphamide for InjectionFDAPresence of Particulate Matter; identified as stainless steel
- Aurobindo Pharma USA Inc recalls Dicyclomine Hydrochloride CapsulesFDAShortfill; reports of empty capsules.
- Central Admixture Pharmacy Services Inc recalls Total Parental NutritionFDAIncorrect Product Formulation
- Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release TabletsFDACGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
- Semaglutide Injection: Incorrect Pen in PackageHealth CanadaPackaging